Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Avanir receives FDA approval for OTC docosanol 10% cream

July 31, 2000

Two human cellular genes necessary for hepatitis C virus growth identified

July 31, 2000

Cubist ready to commence further phase III trials of Cidecin

July 28, 2000

IB-367 active against microflora associated with oral mucositis

July 28, 2000

Micrologix proceeds to next phase of clinical development with MBI-853NL

July 27, 2000

Sordarin derivatives active against C. immitis in vivo

July 27, 2000

U.S. and Italian researchers team up to design new beta-lactamase inhibitors

July 26, 2000

Arrow Therapeutics and Triangle Pharmaceuticals establish collaboration for antiviral agents

July 25, 2000

Numerous antiherpesvirus agents in development at AHP

July 24, 2000

Telithromycin at standard and high doses does not prolong Q-T interval in humans

July 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.